Another anti-VEGF antibody, ranibizumab (Lucentis), a monoclonal antibody Fab, has been successful in the treatment of neovascularization associated with wet neovascular age-related macular degeneration, thereby alleviating blindness in patients [17]. Here, VEGFA is linked to age-related macular degeneration.